Skip to main content
PMC home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1991 Mar;67(785):230–246. doi: 10.1136/pgmj.67.785.230

Hypertension.

G W Ching 1, D G Beevers 1
PMCID: PMC2399022  PMID: 2062770

Full text

PDF
230

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Altura B. M., Altura B. T., Gebrewold A. Alcohol-induced spasms of cerebral blood vessels: relation to cerebrovascular accidents and sudden death. Science. 1983 Apr 15;220(4594):331–333. doi: 10.1126/science.6836278. [DOI] [PubMed] [Google Scholar]
  2. Amery A., Birkenhäger W., Brixko P., Bulpitt C., Clement D., Deruyttere M., De Schaepdryver A., Dollery C., Fagard R., Forette F. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial. Lancet. 1985 Jun 15;1(8442):1349–1354. doi: 10.1016/s0140-6736(85)91783-0. [DOI] [PubMed] [Google Scholar]
  3. Amery A., Birkenhäger W., Brixko R., Bulpitt C., Clement D., Deruyttere M., De Schaepdryver A., Dollery C., Fagard R., Forette F. Efficacy of antihypertensive drug treatment according to age, sex, blood pressure, and previous cardiovascular disease in patients over the age of 60. Lancet. 1986 Sep 13;2(8507):589–592. doi: 10.1016/s0140-6736(86)92424-4. [DOI] [PubMed] [Google Scholar]
  4. Anderson T. W. Re-examination of some of the Framingham blood-pressure data. Lancet. 1978 Nov 25;2(8100):1139–1141. doi: 10.1016/s0140-6736(78)92288-2. [DOI] [PubMed] [Google Scholar]
  5. Baba T., Murabayashi S., Takebe K. Comparison of the renal effects of angiotensin converting enzyme inhibitor and calcium antagonist in hypertensive type 2 (non-insulin-dependent) diabetic patients with microalbuminuria: a randomised controlled trial. Diabetologia. 1989 Jan;32(1):40–44. doi: 10.1007/BF00265402. [DOI] [PubMed] [Google Scholar]
  6. Berkowitz R. L. Anti-hypertensive drugs in the pregnant patient. Obstet Gynecol Surv. 1980 Apr;35(4):191–204. doi: 10.1097/00006254-198004000-00001. [DOI] [PubMed] [Google Scholar]
  7. Bianchi G., Fox U., Di Francesco G. F., Giovanetti A. M., Pagetti D. Blood pressure changes produced by kidney cross-transplantation between spontaneously hypertensive rats and normotensive rats. Clin Sci Mol Med. 1974 Nov;47(5):435–448. doi: 10.1042/cs0470435. [DOI] [PubMed] [Google Scholar]
  8. Bing R. F., Heagerty A. M., Thurston H., Swales J. D. Ion transport in hypertension: are changes in the cell membrane responsible? Clin Sci (Lond) 1986 Sep;71(3):225–230. doi: 10.1042/cs0710225. [DOI] [PubMed] [Google Scholar]
  9. Björck S., Mulec H., Johnsen S. A., Nyberg G., Aurell M. Contrasting effects of enalapril and metoprolol on proteinuria in diabetic nephropathy. BMJ. 1990 Apr 7;300(6729):904–907. doi: 10.1136/bmj.300.6729.904. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Blaustein M. P. Sodium ions, calcium ions, blood pressure regulation, and hypertension: a reassessment and a hypothesis. Am J Physiol. 1977 May;232(5):C165–C173. doi: 10.1152/ajpcell.1977.232.5.C165. [DOI] [PubMed] [Google Scholar]
  11. Broadhurst P., Hughes L. O., Raftery E. B. Non-invasive ambulatory blood pressure monitors: a cautionary note. J Hypertens. 1990 Jul;8(7):595–597. doi: 10.1097/00004872-199007000-00002. [DOI] [PubMed] [Google Scholar]
  12. Buckley B. M., Smith S. C., Beevers M., Beevers D. G., McKiernan M. J. Lack of evidence of low ionized calcium levels in systemic hypertension. Am J Cardiol. 1987 Apr 1;59(8):878–880. doi: 10.1016/0002-9149(87)91111-8. [DOI] [PubMed] [Google Scholar]
  13. Bulpitt C. J., Hodes C., Everitt M. G. The relationship between blood pressure and biochemical risk factors in a general population. Br J Prev Soc Med. 1976 Sep;30(3):158–162. doi: 10.1136/jech.30.3.158. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Bulpitt C. J. Is systolic pressure more important than diastolic pressure? J Hum Hypertens. 1990 Oct;4(5):471–476. [PubMed] [Google Scholar]
  15. Burch P. R. Blood pressure and mortality in the very old. Lancet. 1983 Oct 8;2(8354):852–853. doi: 10.1016/s0140-6736(83)90768-7. [DOI] [PubMed] [Google Scholar]
  16. Butters L., Kennedy S., Rubin P. C. Atenolol in essential hypertension during pregnancy. BMJ. 1990 Sep 22;301(6752):587–589. doi: 10.1136/bmj.301.6752.587. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Collins R., Peto R., MacMahon S., Hebert P., Fiebach N. H., Eberlein K. A., Godwin J., Qizilbash N., Taylor J. O., Hennekens C. H. Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet. 1990 Apr 7;335(8693):827–838. doi: 10.1016/0140-6736(90)90944-z. [DOI] [PubMed] [Google Scholar]
  18. Constantine G., Beevers D. G., Reynolds A. L., Luesley D. M. Nifedipine as a second line antihypertensive drug in pregnancy. Br J Obstet Gynaecol. 1987 Dec;94(12):1136–1142. doi: 10.1111/j.1471-0528.1987.tb02312.x. [DOI] [PubMed] [Google Scholar]
  19. Coope J., Warrender T. S. Randomised trial of treatment of hypertension in elderly patients in primary care. Br Med J (Clin Res Ed) 1986 Nov 1;293(6555):1145–1151. doi: 10.1136/bmj.293.6555.1145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Cruickshank J. M. Coronary flow reserve and the J curve relation between diastolic blood pressure and myocardial infarction. BMJ. 1988 Nov 12;297(6658):1227–1230. doi: 10.1136/bmj.297.6658.1227. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Cruickshank J. M., Thorp J. M., Zacharias F. J. Benefits and potential harm of lowering high blood pressure. Lancet. 1987 Mar 14;1(8533):581–584. doi: 10.1016/s0140-6736(87)90231-5. [DOI] [PubMed] [Google Scholar]
  22. Curzio J. L., Reid J. L., Kennedy S., Elliott H. L., Rubin P. C. Risk factor modification in hypertension--success and failure. J Hum Hypertens. 1987 Sep;1(2):131–136. [PubMed] [Google Scholar]
  23. Davenport A. P., Ashby M. J., Easton P., Ella S., Bedford J., Dickerson C., Nunez D. J., Capper S. J., Brown M. J. A sensitive radioimmunoassay measuring endothelin-like immunoreactivity in human plasma: comparison of levels in patients with essential hypertension and normotensive control subjects. Clin Sci (Lond) 1990 Mar;78(3):261–264. doi: 10.1042/cs0780261. [DOI] [PubMed] [Google Scholar]
  24. DeFronzo R. A., Goldberg M., Agus Z. S. The effects of glucose and insulin on renal electrolyte transport. J Clin Invest. 1976 Jul;58(1):83–90. doi: 10.1172/JCI108463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Drayer J. I., Gardin J. M., Weber M. A., Aronow W. S. Cardiac muscle mass during vasodilation therapy of hypertension. Clin Pharmacol Ther. 1983 Jun;33(6):727–732. doi: 10.1038/clpt.1983.99. [DOI] [PubMed] [Google Scholar]
  26. Drayer J. I., Gardin J. M., Weber M. A., Aronow W. S. Changes in ventricular septal thickness during diuretic therapy. Clin Pharmacol Ther. 1982 Sep;32(3):283–288. doi: 10.1038/clpt.1982.161. [DOI] [PubMed] [Google Scholar]
  27. Dunn F. G., Oigman W., Ventura H. O., Messerli F. H., Kobrin I., Frohlich E. D. Enalapril improves systemic and renal hemodynamics and allows regression of left ventricular mass in essential hypertension. Am J Cardiol. 1984 Jan 1;53(1):105–108. doi: 10.1016/0002-9149(84)90692-1. [DOI] [PubMed] [Google Scholar]
  28. Dunn F. G., Ventura H. O., Messerli F. H., Kobrin I., Frohlich E. D. Time course of regression of left ventricular hypertrophy in hypertensive patients treated with atenolol. Circulation. 1987 Aug;76(2):254–258. doi: 10.1161/01.cir.76.2.254. [DOI] [PubMed] [Google Scholar]
  29. Dyer A. R., Elliott P. The INTERSALT study: relations of body mass index to blood pressure. INTERSALT Co-operative Research Group. J Hum Hypertens. 1989 Oct;3(5):299–308. [PubMed] [Google Scholar]
  30. Dzau V. J., Ingelfinger J., Pratt R. E., Ellison K. E. Identification of renin and angiotensinogen messenger RNA sequences in mouse and rat brains. Hypertension. 1986 Jun;8(6):544–548. doi: 10.1161/01.hyp.8.6.544. [DOI] [PubMed] [Google Scholar]
  31. Edelson J. T., Weinstein M. C., Tosteson A. N., Williams L., Lee T. H., Goldman L. Long-term cost-effectiveness of various initial monotherapies for mild to moderate hypertension. JAMA. 1990 Jan 19;263(3):407–413. [PubMed] [Google Scholar]
  32. Edmondson R. P., Thomas R. D., Hilton P. J., Patrick J., Jones N. F. Abnormal leucocyte composition and sodium transport in essential hypertension. Lancet. 1975 May 3;1(7914):1003–1005. doi: 10.1016/s0140-6736(75)91947-9. [DOI] [PubMed] [Google Scholar]
  33. FOLKOW B., GRIMBY G., THULESIUS O. Adaptive structural changes of the vascular walls in hypertension and their relation to the control of the peripheral resistance. Acta Physiol Scand. 1958 Dec 15;44(3-4):255–272. doi: 10.1111/j.1748-1716.1958.tb01626.x. [DOI] [PubMed] [Google Scholar]
  34. Ferrannini E., Buzzigoli G., Bonadonna R., Giorico M. A., Oleggini M., Graziadei L., Pedrinelli R., Brandi L., Bevilacqua S. Insulin resistance in essential hypertension. N Engl J Med. 1987 Aug 6;317(6):350–357. doi: 10.1056/NEJM198708063170605. [DOI] [PubMed] [Google Scholar]
  35. Ferrannini E., Natali A., Cerri M., Santoro D., Palombo C. Hypertension: a metabolic disorder? Diabete Metab. 1989;15(5 Pt 2):284–291. [PubMed] [Google Scholar]
  36. Ferrara L. A., Fasano M. L., de Simone G., Soro S., Gagliardi R. Antihypertensive and cardiovascular effects of nitrendipine: a controlled study vs. placebo. Clin Pharmacol Ther. 1985 Oct;38(4):434–438. doi: 10.1038/clpt.1985.200. [DOI] [PubMed] [Google Scholar]
  37. Fewings J. D., Hanna M. J., Walsh J. A., Whelan R. F. The effects of ethyl alcohol on the blood vessels of the hand and forearm in man. Br J Pharmacol Chemother. 1966 May;27(1):93–106. doi: 10.1111/j.1476-5381.1966.tb01644.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Fletcher A. E., Beevers D. G., Bulpitt C. J., Butler A., Coles E. C., Hunt D., Munro-Faure A. D., Newson R., O'Riordan P. W., Petrie J. C. The relationship between a low treated blood pressure and IHD mortality: a report from the DHSS Hypertension Care Computing Project (DHCCP). J Hum Hypertens. 1988 Jun;2(1):11–15. [PubMed] [Google Scholar]
  39. Forte J. G., Miguel J. M., Miguel M. J., de Pádua F., Rose G. Salt and blood pressure: a community trial. J Hum Hypertens. 1989 Jun;3(3):179–184. [PubMed] [Google Scholar]
  40. Fouad F. M., Nakashima Y., Tarazi R. C., Salcedo E. E. Reversal of left ventricular hypertrophy in hypertensive patients treated with methyldopa. Lack of association with blood pressure control. Am J Cardiol. 1982 Mar;49(4):795–801. doi: 10.1016/0002-9149(82)91961-0. [DOI] [PubMed] [Google Scholar]
  41. Furchgott R. F., Zawadzki J. V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980 Nov 27;288(5789):373–376. doi: 10.1038/288373a0. [DOI] [PubMed] [Google Scholar]
  42. Gryglewski R. J., Palmer R. M., Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature. 1986 Apr 3;320(6061):454–456. doi: 10.1038/320454a0. [DOI] [PubMed] [Google Scholar]
  43. Harlan W. R., Hull A. L., Schmouder R. L., Landis J. R., Thompson F. E., Larkin F. A. Blood pressure and nutrition in adults. The National Health and Nutrition Examination Survey. Am J Epidemiol. 1984 Jul;120(1):17–28. doi: 10.1093/oxfordjournals.aje.a113870. [DOI] [PubMed] [Google Scholar]
  44. Herlitz H., Fagerberg B., Jonsson O., Hedner T., Andersson O. K., Aurell M. Effects of sodium restriction and energy reduction on erythrocyte sodium transport in obese hypertensive men. Ann Clin Res. 1988;20 (Suppl 48):61–65. [PubMed] [Google Scholar]
  45. Hooke D., Walker R. G., Walter N. M., D'Apice A. J., Whitworth J. A., Kincaid-Smith P. Repeated renal failure with use of captopril in a cystinotic renal allograft recipient. Br Med J (Clin Res Ed) 1982 Nov 27;285(6354):1538–1538. doi: 10.1136/bmj.285.6354.1538. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Hricik D. E., Browning P. J., Kopelman R., Goorno W. E., Madias N. E., Dzau V. J. Captopril-induced functional renal insufficiency in patients with bilateral renal-artery stenoses or renal-artery stenosis in a solitary kidney. N Engl J Med. 1983 Feb 17;308(7):373–376. doi: 10.1056/NEJM198302173080706. [DOI] [PubMed] [Google Scholar]
  47. Hulley S. B., Furberg C. D., Gurland B., McDonald R., Perry H. M., Schnaper H. W., Schoenberger J. A., Smith W. M., Vogt T. M. Systolic Hypertension in the Elderly Program (SHEP): antihypertensive efficacy of chlorthalidone. Am J Cardiol. 1985 Dec 1;56(15):913–920. doi: 10.1016/0002-9149(85)90404-7. [DOI] [PubMed] [Google Scholar]
  48. Kalkhoff R. K., Kim H. J., Cerletty J., Ferrou C. A. Metabolic effects of weight loss in obese subjects. Changes in plasma substrate levels, insulin and growth hormone responses. Diabetes. 1971 Feb;20(2):83–91. doi: 10.2337/diab.20.2.83. [DOI] [PubMed] [Google Scholar]
  49. Kannel W. B., Gordon T., Schwartz M. J. Systolic versus diastolic blood pressure and risk of coronary heart disease. The Framingham study. Am J Cardiol. 1971 Apr;27(4):335–346. doi: 10.1016/0002-9149(71)90428-0. [DOI] [PubMed] [Google Scholar]
  50. Kesteloot H., Geboers J. Calcium and blood pressure. Lancet. 1982 Apr 10;1(8276):813–815. doi: 10.1016/s0140-6736(82)91870-0. [DOI] [PubMed] [Google Scholar]
  51. Khaw K. T., Thom S. Randomised double-blind cross-over trial of potassium on blood-pressure in normal subjects. Lancet. 1982 Nov 20;2(8308):1127–1129. doi: 10.1016/s0140-6736(82)92787-8. [DOI] [PubMed] [Google Scholar]
  52. Krishnaswami K. V., Abdul Rahim M., Seshagiri K., Radhakrishna S., Satagopan M. C., Somasundaram P. R., Tripathy S. P., Fox W. Study of a policy to minimise the prescription of medicaments at first attendance at chest clinics. Lancet. 1982 Aug 28;2(8296):483–486. doi: 10.1016/s0140-6736(82)90505-0. [DOI] [PubMed] [Google Scholar]
  53. LEVER A. F., PEART W. S. Renin and angiotensin-like activity in renal lymph. J Physiol. 1962 Mar;160:548–563. doi: 10.1113/jphysiol.1962.sp006865. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Landin K., Krotkiewski M., Smith U. Importance of obesity for the metabolic abnormalities associated with an abdominal fat distribution. Metabolism. 1989 Jun;38(6):572–576. doi: 10.1016/0026-0495(89)90219-9. [DOI] [PubMed] [Google Scholar]
  55. Lang R. E., Unger T., Ganten D. Atrial natriuretic peptide: a new factor in blood pressure control. J Hypertens. 1987 Jun;5(3):255–271. doi: 10.1097/00004872-198706000-00001. [DOI] [PubMed] [Google Scholar]
  56. Langford H. G. Dietary potassium and hypertension: epidemiologic data. Ann Intern Med. 1983 May;98(5 Pt 2):770–772. doi: 10.7326/0003-4819-98-5-770. [DOI] [PubMed] [Google Scholar]
  57. Lapidus L., Bengtsson C., Larsson B., Pennert K., Rybo E., Sjöström L. Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden. Br Med J (Clin Res Ed) 1984 Nov 10;289(6454):1257–1261. doi: 10.1136/bmj.289.6454.1257. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Larsson B., Svärdsudd K., Welin L., Wilhelmsen L., Björntorp P., Tibblin G. Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913. Br Med J (Clin Res Ed) 1984 May 12;288(6428):1401–1404. doi: 10.1136/bmj.288.6428.1401. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Lechi C., Sinigaglia D., Corsato M., Covi G., Arosio E., Lechi A. Intracellular free Ca2+ in platelets of essential hypertensive patients. Lack of correlation with clinical and laboratory data. J Hum Hypertens. 1988 Jun;2(1):49–52. [PubMed] [Google Scholar]
  60. Leren P. Comparison of effects on lipid metabolism of antihypertensive drugs with alpha- and beta-adrenergic antagonist properties. Am J Med. 1987 Jan 5;82(1A):31–35. doi: 10.1016/0002-9343(87)90141-0. [DOI] [PubMed] [Google Scholar]
  61. Lever A. F. Slow pressor mechanisms in hypertension: a role for hypertrophy of resistance vessels? J Hypertens. 1986 Oct;4(5):515–524. doi: 10.1097/00004872-198610000-00001. [DOI] [PubMed] [Google Scholar]
  62. Lichtenstein M. J., Shipley M. J., Rose G. Systolic and diastolic blood pressures as predictors of coronary heart disease mortality in the Whitehall study. Br Med J (Clin Res Ed) 1985 Jul 27;291(6490):243–245. doi: 10.1136/bmj.291.6490.243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Luft F. C., Weinberger M. H., Grim C. E. Sodium sensitivity and resistance in normotensive humans. Am J Med. 1982 May;72(5):726–736. doi: 10.1016/0002-9343(82)90537-x. [DOI] [PubMed] [Google Scholar]
  64. MacGregor G. A., Markandu N. D., Best F. E., Elder D. M., Cam J. M., Sagnella G. A., Squires M. Double-blind randomised crossover trial of moderate sodium restriction in essential hypertension. Lancet. 1982 Feb 13;1(8268):351–355. doi: 10.1016/s0140-6736(82)91389-7. [DOI] [PubMed] [Google Scholar]
  65. MacGregor G. A., Markandu N. D., Sagnella G. A., Singer D. R., Cappuccio F. P. Double-blind study of three sodium intakes and long-term effects of sodium restriction in essential hypertension. Lancet. 1989 Nov 25;2(8674):1244–1247. doi: 10.1016/s0140-6736(89)91852-7. [DOI] [PubMed] [Google Scholar]
  66. MacGregor G. A., Smith S. J., Markandu N. D., Banks R. A., Sagnella G. A. Moderate potassium supplementation in essential hypertension. Lancet. 1982 Sep 11;2(8298):567–570. doi: 10.1016/s0140-6736(82)90657-2. [DOI] [PubMed] [Google Scholar]
  67. MacGregor G. A. Sodium is more important than calcium in essential hypertension. Hypertension. 1985 Jul-Aug;7(4):628–640. doi: 10.1161/01.hyp.7.4.628. [DOI] [PubMed] [Google Scholar]
  68. MacMahon S., Peto R., Cutler J., Collins R., Sorlie P., Neaton J., Abbott R., Godwin J., Dyer A., Stamler J. Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet. 1990 Mar 31;335(8692):765–774. doi: 10.1016/0140-6736(90)90878-9. [DOI] [PubMed] [Google Scholar]
  69. Man in 't Veld A. J., Schicht I. M., Derkx F. H., de Bruyn J. H., Schalekamp M. A. Effects of an angiotensin-converting enzyme inhibitor (captopril) on blood pressure in anephric subjects. Br Med J. 1980 Feb 2;280(6210):288–290. doi: 10.1136/bmj.280.6210.288. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Mann A. H. The psychological effect of a screening programme and clinical trial for hypertension upon the participants. Psychol Med. 1977 Aug;7(3):431–438. doi: 10.1017/s0033291700004402. [DOI] [PubMed] [Google Scholar]
  71. Mann S., Millar Craig M. W., Raftery E. B. Superiority of 24-hour measurement of blood pressure over clinic values in determining prognosis in hypertension. Clin Exp Hypertens A. 1985;7(2-3):279–281. doi: 10.3109/10641968509073547. [DOI] [PubMed] [Google Scholar]
  72. Marshall J. J., Wei E. P., Kontos H. A. Independent blockade of cerebral vasodilation from acetylcholine and nitric oxide. Am J Physiol. 1988 Oct;255(4 Pt 2):H847–H854. doi: 10.1152/ajpheart.1988.255.4.H847. [DOI] [PubMed] [Google Scholar]
  73. Masugi F., Ogihara T., Hashizume K., Hasegawa T., Sakaguchi K., Kumahara Y. Changes in plasma lipids and uric acid with sodium loading and sodium depletion in patients with essential hypertension. J Hum Hypertens. 1988 Mar;1(4):293–298. [PubMed] [Google Scholar]
  74. Mattila K., Haavisto M., Rajala S., Heikinheimo R. Blood pressure and five year survival in the very old. Br Med J (Clin Res Ed) 1988 Mar 26;296(6626):887–889. doi: 10.1136/bmj.296.6626.887. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. McCarron D. A. Is calcium more important than sodium in the pathogenesis of essential hypertension? Hypertension. 1985 Jul-Aug;7(4):607–627. doi: 10.1161/01.hyp.7.4.607. [DOI] [PubMed] [Google Scholar]
  76. McCarron D. A., Morris C. D. Blood pressure response to oral calcium in persons with mild to moderate hypertension. A randomized, double-blind, placebo-controlled, crossover trial. Ann Intern Med. 1985 Dec;103(6 ):825–831. doi: 10.7326/0003-4819-103-6-825. [DOI] [PubMed] [Google Scholar]
  77. McCarron D. A., Morris C. D., Cole C. Dietary calcium in human hypertension. Science. 1982 Jul 16;217(4556):267–269. doi: 10.1126/science.7089566. [DOI] [PubMed] [Google Scholar]
  78. Meade T. W., Imeson J. D., Gordon D., Peart W. S. The epidemiology of plasma renin. Clin Sci (Lond) 1983 Mar;64(3):273–280. doi: 10.1042/cs0640273. [DOI] [PubMed] [Google Scholar]
  79. Modan M., Halkin H., Almog S., Lusky A., Eshkol A., Shefi M., Shitrit A., Fuchs Z. Hyperinsulinemia. A link between hypertension obesity and glucose intolerance. J Clin Invest. 1985 Mar;75(3):809–817. doi: 10.1172/JCI111776. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Mogensen C. E. Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy. Br Med J (Clin Res Ed) 1982 Sep 11;285(6343):685–688. doi: 10.1136/bmj.285.6343.685. [DOI] [PMC free article] [PubMed] [Google Scholar]
  81. Mogensen C. E. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med. 1984 Feb 9;310(6):356–360. doi: 10.1056/NEJM198402093100605. [DOI] [PubMed] [Google Scholar]
  82. Muiesan G., Agabiti-Rosei E., Romanelli G., Muiesan M. L., Castellano M., Beschi M. Adrenergic activity and left ventricular function during treatment of essential hypertension with calcium antagonists. Am J Cardiol. 1986 Feb 26;57(7):44D–49D. doi: 10.1016/0002-9149(86)90805-2. [DOI] [PubMed] [Google Scholar]
  83. Nakashima Y., Fouad F. M., Tarazi R. C. Regression of left ventricular hypertrophy from systemic hypertension by enalapril. Am J Cardiol. 1984 Apr 1;53(8):1044–1049. doi: 10.1016/0002-9149(84)90634-9. [DOI] [PubMed] [Google Scholar]
  84. O'Brien E., Petrie J., Littler W., de Swiet M., Padfield P. L., O'Malley K., Jamieson M., Altman D., Bland M., Atkins N. The British Hypertension Society protocol for the evaluation of automated and semi-automated blood pressure measuring devices with special reference to ambulatory systems. J Hypertens. 1990 Jul;8(7):607–619. doi: 10.1097/00004872-199007000-00004. [DOI] [PubMed] [Google Scholar]
  85. PAGE I. H. The nature of arterial hypertension. Arch Intern Med. 1963 Jan;111:103–115. doi: 10.1001/archinte.1963.03620250107016. [DOI] [PubMed] [Google Scholar]
  86. Pacy P. J., Dodson P. M., Beevers M., Fletcher R. F., Taylor K. G. Prevalence of hypertension in white, black and Asian diabetics in a district hospital diabetic clinic. Diabet Med. 1985 Mar;2(2):125–130. doi: 10.1111/j.1464-5491.1985.tb00615.x. [DOI] [PubMed] [Google Scholar]
  87. Palmer R. M., Ferrige A. G., Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987 Jun 11;327(6122):524–526. doi: 10.1038/327524a0. [DOI] [PubMed] [Google Scholar]
  88. Parati G., Pomidossi G., Albini F., Malaspina D., Mancia G. Relationship of 24-hour blood pressure mean and variability to severity of target-organ damage in hypertension. J Hypertens. 1987 Feb;5(1):93–98. doi: 10.1097/00004872-198702000-00013. [DOI] [PubMed] [Google Scholar]
  89. Parati G., Pomidossi G., Casadei R., Mancia G. Lack of alerting reactions to intermittent cuff inflations during noninvasive blood pressure monitoring. Hypertension. 1985 Jul-Aug;7(4):597–601. doi: 10.1161/01.hyp.7.4.597. [DOI] [PubMed] [Google Scholar]
  90. Parker M., Puddey I. B., Beilin L. J., Vandongen R. Two-way factorial study of alcohol and salt restriction in treated hypertensive men. Hypertension. 1990 Oct;16(4):398–406. doi: 10.1161/01.hyp.16.4.398. [DOI] [PubMed] [Google Scholar]
  91. Parving H. H., Hommel E., Smidt U. M. Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy. BMJ. 1988 Oct 29;297(6656):1086–1091. doi: 10.1136/bmj.297.6656.1086. [DOI] [PMC free article] [PubMed] [Google Scholar]
  92. Patel C., Marmot M. G., Terry D. J., Carruthers M., Hunt B., Patel M. Trial of relaxation in reducing coronary risk: four year follow up. Br Med J (Clin Res Ed) 1985 Apr 13;290(6475):1103–1106. doi: 10.1136/bmj.290.6475.1103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  93. Patel C., Marmot M. G., Terry D. J. Controlled trial of biofeedback-aided behavioural methods in reducing mild hypertension. Br Med J (Clin Res Ed) 1981 Jun 20;282(6281):2005–2008. doi: 10.1136/bmj.282.6281.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  94. Patki P. S., Singh J., Gokhale S. V., Bulakh P. M., Shrotri D. S., Patwardhan B. Efficacy of potassium and magnesium in essential hypertension: a double-blind, placebo controlled, crossover study. BMJ. 1990 Sep 15;301(6751):521–523. doi: 10.1136/bmj.301.6751.521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  95. Perloff D., Sokolow M., Cowan R. The prognostic value of ambulatory blood pressures. JAMA. 1983 May 27;249(20):2792–2798. [PubMed] [Google Scholar]
  96. Petrie J. C., O'Brien E. T., Littler W. A., de Swiet M. Recommendations on blood pressure measurement. Br Med J (Clin Res Ed) 1986 Sep 6;293(6547):611–615. doi: 10.1136/bmj.293.6547.611. [DOI] [PMC free article] [PubMed] [Google Scholar]
  97. Pickering T. G., Devereux R. B. Ambulatory monitoring of blood pressure as a predictor of cardiovascular risk. Am Heart J. 1987 Oct;114(4 Pt 2):925–928. doi: 10.1016/0002-8703(87)90589-8. [DOI] [PubMed] [Google Scholar]
  98. Pickering T. G., Harshfield G. A., Devereux R. B., Laragh J. H. What is the role of ambulatory blood pressure monitoring in the management of hypertensive patients? Hypertension. 1985 Mar-Apr;7(2):171–177. doi: 10.1161/01.hyp.7.2.171. [DOI] [PubMed] [Google Scholar]
  99. Pickering T. G., Harshfield G. A., Kleinert H. D., Blank S., Laragh J. H. Blood pressure during normal daily activities, sleep, and exercise. Comparison of values in normal and hypertensive subjects. JAMA. 1982 Feb 19;247(7):992–996. [PubMed] [Google Scholar]
  100. Pickering T. G., James G. D., Boddie C., Harshfield G. A., Blank S., Laragh J. H. How common is white coat hypertension? JAMA. 1988 Jan 8;259(2):225–228. [PubMed] [Google Scholar]
  101. Pollare T., Lithell H., Berne C. A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension. N Engl J Med. 1989 Sep 28;321(13):868–873. doi: 10.1056/NEJM198909283211305. [DOI] [PubMed] [Google Scholar]
  102. Pollare T., Lithell H., Mörlin C., Präntare H., Hvarfner A., Ljunghall S. Metabolic effects of diltiazem and atenolol: results from a randomized, double-blind study with parallel groups. J Hypertens. 1989 Jul;7(7):551–559. doi: 10.1097/00004872-198907000-00006. [DOI] [PubMed] [Google Scholar]
  103. Potter J. F., Bannan L. T., Saunders J. B., Ingram M. C., Beevers D. G. Blood pressure and pressor mechanisms during alcohol withdrawal. J Hypertens Suppl. 1983 Dec;1(2):97–99. [PubMed] [Google Scholar]
  104. Potter J. F., Beevers D. G. Pressor effect of alcohol in hypertension. Lancet. 1984 Jan 21;1(8369):119–122. doi: 10.1016/s0140-6736(84)90060-6. [DOI] [PubMed] [Google Scholar]
  105. Potter J. F., Macdonald I. A., Beevers D. G. Alcohol raises blood pressure in hypertensive patients. J Hypertens. 1986 Aug;4(4):435–441. doi: 10.1097/00004872-198608000-00007. [DOI] [PubMed] [Google Scholar]
  106. Poulter N. R., Khaw K. T., Hopwood B. E., Mugambi M., Peart W. S., Rose G., Sever P. S. The Kenyan Luo migration study: observations on the initiation of a rise in blood pressure. BMJ. 1990 Apr 14;300(6730):967–972. doi: 10.1136/bmj.300.6730.967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  107. Poulter N., Khaw K. T., Hopwood B. E., Mugambi M., Peart W. S., Rose G., Sever P. S. Blood pressure and associated factors in a rural Kenyan community. Hypertension. 1984 Nov-Dec;6(6 Pt 1):810–813. doi: 10.1161/01.hyp.6.6.810. [DOI] [PubMed] [Google Scholar]
  108. Puddey I. B., Beilin L. J., Vandongen R. Regular alcohol use raises blood pressure in treated hypertensive subjects. A randomised controlled trial. Lancet. 1987 Mar 21;1(8534):647–651. doi: 10.1016/s0140-6736(87)90413-2. [DOI] [PubMed] [Google Scholar]
  109. Puddey I. B., Vandongen R., Beilin L. J., Rouse I. L. Alcohol stimulation of renin release in man: its relation to the hemodynamic, electrolyte, and sympatho-adrenal responses to drinking. J Clin Endocrinol Metab. 1985 Jul;61(1):37–42. doi: 10.1210/jcem-61-1-37. [DOI] [PubMed] [Google Scholar]
  110. Ramsay L. E., Waller P. C. Strokes in mild hypertension: diastolic rules. Lancet. 1986 Oct 11;2(8511):854–856. doi: 10.1016/s0140-6736(86)92884-9. [DOI] [PubMed] [Google Scholar]
  111. Reaven G. M. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988 Dec;37(12):1595–1607. doi: 10.2337/diab.37.12.1595. [DOI] [PubMed] [Google Scholar]
  112. Reichek N., Devereux R. B. Left ventricular hypertrophy: relationship of anatomic, echocardiographic and electrocardiographic findings. Circulation. 1981 Jun;63(6):1391–1398. doi: 10.1161/01.cir.63.6.1391. [DOI] [PubMed] [Google Scholar]
  113. Rose G., Stamler J. The INTERSALT study: background, methods and main results. INTERSALT Co-operative Research Group. J Hum Hypertens. 1989 Oct;3(5):283–288. [PubMed] [Google Scholar]
  114. Rowe J. W., Young J. B., Minaker K. L., Stevens A. L., Pallotta J., Landsberg L. Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man. Diabetes. 1981 Mar;30(3):219–225. doi: 10.2337/diab.30.3.219. [DOI] [PubMed] [Google Scholar]
  115. Safar M. E. Pulse pressure in essential hypertension: clinical and therapeutical implications. J Hypertens. 1989 Oct;7(10):769–776. doi: 10.1097/00004872-198910000-00001. [DOI] [PubMed] [Google Scholar]
  116. Sagnella G. A., MacGregor G. A. Atrial natriuretic peptides. Q J Med. 1990 Oct;77(282):1001–1007. doi: 10.1093/qjmed/77.1.1001. [DOI] [PubMed] [Google Scholar]
  117. Samuelsson O., Wilhelmsen L., Andersson O. K., Pennert K., Berglund G. Cardiovascular morbidity in relation to change in blood pressure and serum cholesterol levels in treated hypertension. Results from the primary prevention trial in Göteborg, Sweden. JAMA. 1987 Oct 2;258(13):1768–1776. [PubMed] [Google Scholar]
  118. Sen S., Bumpus F. M. Collagen synthesis in development and reversal of cardiac hypertrophy in spontaneously hypertensive rats. Am J Cardiol. 1979 Oct 22;44(5):954–958. doi: 10.1016/0002-9149(79)90228-5. [DOI] [PubMed] [Google Scholar]
  119. Sen S., Tarazi R. C., Bumpus F. M. Cardiac hypertrophy and antihypertensive therapy. Cardiovasc Res. 1977 Sep;11(5):427–433. doi: 10.1093/cvr/11.5.427. [DOI] [PubMed] [Google Scholar]
  120. Shaper A. G., Wannamethee G., Whincup P. Alcohol and blood pressure in middle-aged British men. J Hum Hypertens. 1988 Aug;2(2):71–78. [PubMed] [Google Scholar]
  121. Shinton R. A., Beevers D. G. A meta-analysis of mortality and coronary prevention in hypertensive patients treated with beta-receptor blockers. J Hum Hypertens. 1990 Jun;4 (Suppl 2):31–34. [PubMed] [Google Scholar]
  122. Sibai B. M., Mabie W. C., Shamsa F., Villar M. A., Anderson G. D. A comparison of no medication versus methyldopa or labetalol in chronic hypertension during pregnancy. Am J Obstet Gynecol. 1990 Apr;162(4):960–967. doi: 10.1016/0002-9378(90)91297-p. [DOI] [PubMed] [Google Scholar]
  123. Simon G., Morioka S., Snyder D. K., Cohn J. N. Increased renal plasma flow in long-term enalapril treatment of hypertension. Clin Pharmacol Ther. 1983 Oct;34(4):459–465. doi: 10.1038/clpt.1983.198. [DOI] [PubMed] [Google Scholar]
  124. Singer P., Gödicke W., Voigt S., Hajdu I., Weiss M. Postprandial hyperinsulinemia in patients with mild essential hypertension. Hypertension. 1985 Mar-Apr;7(2):182–186. doi: 10.1161/01.hyp.7.2.182. [DOI] [PubMed] [Google Scholar]
  125. Staessen J., Fagard R., Amery A. The relationship between body weight and blood pressure. J Hum Hypertens. 1988 Dec;2(4):207–217. [PubMed] [Google Scholar]
  126. Stamler J., Wentworth D., Neaton J. D. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA. 1986 Nov 28;256(20):2823–2828. [PubMed] [Google Scholar]
  127. Stamler R., Stamler J., Riedlinger W. F., Algera G., Roberts R. H. Family (parental) history and prevalence of hypertension. Results of a nationwide screening program. JAMA. 1979 Jan 5;241(1):43–46. [PubMed] [Google Scholar]
  128. Stewart I. M. Relation of reduction in pressure to first myocardial infarction in patients receiving treatment for severe hypertension. Lancet. 1979 Apr 21;1(8121):861–865. doi: 10.1016/s0140-6736(79)91274-1. [DOI] [PubMed] [Google Scholar]
  129. Stott F. D., Terry V. G., Honour A. J. Factors determining the design and construction of a portable pressure transducer system. Postgrad Med J. 1976;52 (Suppl 7):97–99. [PubMed] [Google Scholar]
  130. Stout R. W., Bierman E. L., Ross R. Effect of insulin on the proliferation of cultured primate arterial smooth muscle cells. Circ Res. 1975 Feb;36(2):319–327. doi: 10.1161/01.res.36.2.319. [DOI] [PubMed] [Google Scholar]
  131. Svedberg J., Björntorp P., Smith U., Lönnroth P. Free-fatty acid inhibition of insulin binding, degradation, and action in isolated rat hepatocytes. Diabetes. 1990 May;39(5):570–574. doi: 10.2337/diab.39.5.570. [DOI] [PubMed] [Google Scholar]
  132. Svärdsudd K., Tibblin G. A longitudinal blood pressure study. Change of blood pressure during 10 yr in relation to initial values. The study of men born in 1913. J Chronic Dis. 1980;33(10):627–636. doi: 10.1016/0021-9681(80)90005-3. [DOI] [PubMed] [Google Scholar]
  133. Swales J. D. First line treatment in hypertension. BMJ. 1990 Nov 24;301(6762):1172–1173. doi: 10.1136/bmj.301.6762.1172. [DOI] [PMC free article] [PubMed] [Google Scholar]
  134. Thom S., Hughes A., Martin G., Sever P. S. Endothelium-dependent relaxation in isolated human arteries and veins. Clin Sci (Lond) 1987 Nov;73(5):547–552. doi: 10.1042/cs0730547. [DOI] [PubMed] [Google Scholar]
  135. Thurston H., Swales J. D. Converting enzyme inhibitor and saralasin infusion in rats. Evidence for an additional vasodepressor property of converting enzyme inhibitor. Circ Res. 1978 May;42(5):588–592. doi: 10.1161/01.res.42.5.588. [DOI] [PubMed] [Google Scholar]
  136. Ueshima H., Ogihara T., Baba S., Tabuchi Y., Mikawa K., Hashizume K., Mandai T., Ozawa H., Kumahara Y., Asakura S. The effect of reduced alcohol consumption on blood pressure: a randomised, controlled, single blind study. J Hum Hypertens. 1987 Sep;1(2):113–119. [PubMed] [Google Scholar]
  137. Unger T., Yukimura T., Marin-Grez M., Lang R. E., Rascher W., Ganten D. SA446, a new orally active converting enzyme inhibitor: antihypertensive action and comparison with captopril in stroke-prone spontaneously hypersensitive rats. Eur J Pharmacol. 1982 Mar 26;78(4):411–420. doi: 10.1016/0014-2999(82)90483-6. [DOI] [PubMed] [Google Scholar]
  138. VanBenthuysen K. M., McMurtry I. F., Horwitz L. D. Reperfusion after acute coronary occlusion in dogs impairs endothelium-dependent relaxation to acetylcholine and augments contractile reactivity in vitro. J Clin Invest. 1987 Jan;79(1):265–274. doi: 10.1172/JCI112793. [DOI] [PMC free article] [PubMed] [Google Scholar]
  139. Velletri P. A. Testicular angiotensin I-converting enzyme (E.C. 3.4.15.1). Life Sci. 1985 Apr 29;36(17):1597–1608. doi: 10.1016/0024-3205(85)90362-5. [DOI] [PubMed] [Google Scholar]
  140. Waller P. C., Isles C. G., Lever A. F., Murray G. D., McInnes G. T. Does therapeutic reduction of diastolic blood pressure cause death from coronary heart disease? J Hum Hypertens. 1988 Jun;2(1):7–10. [PubMed] [Google Scholar]
  141. Watson M. L., Bell G. M., Muir A. L., Buist T. A., Kellett R. J., Padfield P. L. Captopril/diuretic combinations in severe renovascular disease: a cautionary note. Lancet. 1983 Aug 13;2(8346):404–405. doi: 10.1016/s0140-6736(83)90376-8. [DOI] [PubMed] [Google Scholar]
  142. Watt G. C., Edwards C., Hart J. T., Hart M., Walton P., Foy C. J. Dietary sodium restriction for mild hypertension in general practice. Br Med J (Clin Res Ed) 1983 Feb 5;286(6363):432–436. doi: 10.1136/bmj.286.6363.432. [DOI] [PMC free article] [PubMed] [Google Scholar]
  143. Weber M. A., Drayer J. I., Nakamura D. K., Wyle F. A. The circadian blood pressure pattern in ambulatory normal subjects. Am J Cardiol. 1984 Jul 1;54(1):115–119. doi: 10.1016/0002-9149(84)90314-x. [DOI] [PubMed] [Google Scholar]
  144. Weissberg P. L., Woods K. L., West M. J., Beevers D. G. Genetic and ethnic influences on the distribution of sodium and potassium in normotensive and hypertensive subjects. J Clin Hypertens. 1987 Mar;3(1):20–25. [PubMed] [Google Scholar]
  145. Welborn T. A., Breckenridge A., Rubinstein A. H., Dollery C. T., Fraser T. R. Serum-insulin in essential hypertension and in peripheral vascular disease. Lancet. 1966 Jun 18;1(7451):1336–1337. doi: 10.1016/s0140-6736(66)92132-5. [DOI] [PubMed] [Google Scholar]
  146. White W. B. Assessment of patients with office hypertension by 24-hour noninvasive ambulatory blood pressure monitoring. Arch Intern Med. 1986 Nov;146(11):2196–2199. [PubMed] [Google Scholar]
  147. White W. B., Dey H. M., Schulman P. Assessment of the daily blood pressure load as a determinant of cardiac function in patients with mild-to-moderate hypertension. Am Heart J. 1989 Oct;118(4):782–795. doi: 10.1016/0002-8703(89)90593-0. [DOI] [PubMed] [Google Scholar]
  148. White W. B., Morganroth J. Usefulness of ambulatory monitoring of blood pressure in assessing antihypertensive therapy. Am J Cardiol. 1989 Jan 1;63(1):94–98. doi: 10.1016/0002-9149(89)91083-7. [DOI] [PubMed] [Google Scholar]
  149. Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., Yazaki Y., Goto K., Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988 Mar 31;332(6163):411–415. doi: 10.1038/332411a0. [DOI] [PubMed] [Google Scholar]
  150. Yusuf S., Peto R., Lewis J., Collins R., Sleight P. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis. 1985 Mar-Apr;27(5):335–371. doi: 10.1016/s0033-0620(85)80003-7. [DOI] [PubMed] [Google Scholar]
  151. Zatz R., Dunn B. R., Meyer T. W., Anderson S., Rennke H. G., Brenner B. M. Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest. 1986 Jun;77(6):1925–1930. doi: 10.1172/JCI112521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  152. de Wardener H. E., MacGregor G. A. The natriuretic hormone and essential hypertension. Lancet. 1982 Jun 26;1(8287):1450–1454. doi: 10.1016/s0140-6736(82)92462-x. [DOI] [PubMed] [Google Scholar]
  153. van Montfrans G. A., Karemaker J. M., Wieling W., Dunning A. J. Relaxation therapy and continuous ambulatory blood pressure in mild hypertension: a controlled study. BMJ. 1990 May 26;300(6736):1368–1372. doi: 10.1136/bmj.300.6736.1368. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES